An experimental drug stops advanced breast cancer from progressing in some people with tumors that have grown resistant to ...
A groundbreaking international study has found that imlunestrant plus abemaciclib significantly improved progression-free survival (PFS) versus imlunestrant monotherapy in patients with estrogen ...
Researchers from Memorial Sloan Kettering Cancer Center to present the latest advances in blood cancer during The American ...
The FDA has granted accelerated approval to zenocutuzumab for treating patients with advanced pancreatic cancer or non-small ...
Learn how it's possible to stay active even with two types of advanced cancer — lung cancer and mantle cell lymphoma — thanks ...
MSK is among 77 hospitals recognized by the American College of Surgeons National Surgical Quality Improvement Program (ACS ...
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
Ready to start planning your care? Call us at 800-525-2225 to make an appointment.
A study from the lab of Dr. Tuomas Tammela and collaborators provides evidence about how advanced age can be protective against cancer — with implications for treating patients in different age groups ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback